Critical appraisal:Arenas M, Arguís M, Díez-Presa L, Henríquez I, Murcia-Mejía M, Gascón M, et al 2015 4

From Cancer Guidelines Wiki

Risk of bias assessment: case series

Subject selection:
Highly selected or not described (e.g. single-institution study)
Were the outcome measures blind to pre/post-intervention?
No or not described
Follow-up complete and all patients included in the analysis?
Yes (follow-up >95%)
Overall risk of bias
High risk of bias Additional comments:


Jutta's tick icon.png This appraisal has been completed.


Article
Arenas M, Arguís M, Díez-Presa L, Henríquez I, Murcia-Mejía M, Gascón M, et al. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment. Brachytherapy 2015 Nov;14(6):859-65 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26489922.
Assigned to
User:Annika.stollery
Topic area
Guidelines:Keratinocyte carcinoma
Clinical question
Form
Form:Quality appraisal cs
Outcomes
3-year disease-free survival; 5-year disease-free survival; Late toxicity

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment